Description

6-Bromo-2-Ethyl-n-Methylimidazo[1,2-A]Pyridin-3-Amine is a high-purity, advanced pharmaceutical intermediate belonging to the imidazopyridine class of heterocyclic compounds. This compound matters as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) and anti-infective drug candidates. Pharmaceutical R&D teams and fine chemical manufacturers need this specific intermediate for its role in constructing complex molecular architectures with potential therapeutic activity.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the development of new drug candidates, especially for neurological and psychiatric disorders.
• Active Pharmaceutical Ingredient (API) Synthesis: Used in the multi-step synthesis of complex APIs targeting specific biological pathways.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Tool Compound: Potential use in developing probes for studying enzyme inhibition or receptor binding in biochemical assays.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	6-Bromo-2-Ethyl-n-Methylimidazo[1,2-A]Pyridin-3-Amine
CAS No.	1628264-05-0
Molecular Formula	C10H12BrN3
Molecular Weight	254.13 g/mol
Synonyms	6-Bromo-2-ethyl-N-methylimidazo[1,2-a]pyridin-3-amine; 2-Ethyl-6-bromo-N-methylimidazo[1,2-a]pyridin-3-amine; 6-Bromo-2-ethyl-3-(methylamino)imidazo[1,2-a]pyridine; 1628264-05-0; Imidazo[1,2-a]pyridin-3-amine, 6-bromo-2-ethyl-N-methyl-; 6-Bromo-2-ethyl-3-methylaminoimidazo[1,2-a]pyridine
EINECS	Contact for details

Quality Control

Our 6-Bromo-2-Ethyl-n-Methylimidazo[1,2-A]Pyridin-3-Amine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specified parameters. Our quality commitment aligns with cGMP standards for pharmaceutical intermediates, ensuring reliability for critical research and development applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep container tightly sealed when not in use to protect from moisture.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.